» Articles » PMID: 37605097

Gut Microbiota Metabolites Mediate Bax to Reduce Neuronal Apoptosis Via CGAS/STING Axis in Epilepsy

Overview
Journal Mol Neurobiol
Date 2023 Aug 21
PMID 37605097
Authors
Affiliations
Soon will be listed here.
Abstract

The beneficial effects of gut flora on reducing nerve cell apoptosis and inflammation and improving epilepsy (EP) symptoms have been reported, but the specific mechanism of action is still unclear. A series of in vitro and in vivo experiments revealed the relationship between gut microbiota metabolites and the cGAS/STING axis and their role in EP. These results suggest that antibiotic-induced dysbiosis of gut microbiota exacerbated epileptic symptoms, probiotic supplements reduced epileptic symptoms in mice. Antibiotics and probiotics altered the diversity and composition of gut microbiota. The changes in gut bacteria composition, such as in the abundance of Firmicutes, Bacteroidetes, Lactobacillus and Ruminococcus, were associated with the production of short-chain fatty acids (SCFA) in the gut. The concentrations of propionate, butyrate and isovalerate were changed after feeding antibiotics and probiotics, and the increase in butyrate levels reduced the expression of cGAS/STING in nerve cell further reduced Bax protein expression. The reduction of Bax protein attenuated the hippocampal neuron cell apoptosis in PTZ-induced EP and EP progression. Our findings provide new insights into the roles and mechanisms of action of the gut microbiota in attenuating EP symptoms and progression.

Citing Articles

Berberine Alleviates Kainic Acid-Induced Acute Epileptic Seizures in Mice via Reshaping Gut Microbiota-Associated Lipid Metabolism.

Dai W, Zhu Y, Jiang Z, Xiang Y, Mao X, Liu Z CNS Neurosci Ther. 2025; 31(2):e70253.

PMID: 39915895 PMC: 11802332. DOI: 10.1111/cns.70253.


Integrated Macrogenomics and Metabolomics Explore Alterations and Correlation between Gut Microbiota and Serum Metabolites in Adult Epileptic Patients: A Pilot Study.

Zhou K, Jia L, Mao Z, Si P, Sun C, Qu Z Microorganisms. 2023; 11(11).

PMID: 38004640 PMC: 10672912. DOI: 10.3390/microorganisms11112628.

References
1.
Zack M, Kobau R . National and State Estimates of the Numbers of Adults and Children with Active Epilepsy - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017; 66(31):821-825. PMC: 5687788. DOI: 10.15585/mmwr.mm6631a1. View

2.
Viaud S, Daillere R, Boneca I, Lepage P, Langella P, Chamaillard M . Gut microbiome and anticancer immune response: really hot Sh*t!. Cell Death Differ. 2014; 22(2):199-214. PMC: 4291500. DOI: 10.1038/cdd.2014.56. View

3.
Tremlett H, Fadrosh D, Faruqi A, Zhu F, Hart J, Roalstad S . Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol. 2016; 23(8):1308-1321. PMC: 4955679. DOI: 10.1111/ene.13026. View

4.
Forsyth C, Shannon K, Kordower J, Voigt R, Shaikh M, Jaglin J . Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One. 2011; 6(12):e28032. PMC: 3228722. DOI: 10.1371/journal.pone.0028032. View

5.
Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J . Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 2013; 127(2):235-41. DOI: 10.1007/s00401-013-1214-6. View